Here's what is coming soon to NeurologyLive.
Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
On Wednesday, June 16, 2021, at 7PM ET, the third installment of our free webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, will broadcast! It features a detailed discussion on the evolution of diagnosis and treating multiple sclerosis care during a pandemic featuring Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD.
Last week, on Monday, June 7, the FDA approved the controversial and investigational Alzheimer disease treatment aducanumab (Aduhelm) after its 2-year journey to get in front of the regulatory agency. NeurologyLive covered this news as soon as it happened and has continued to discuss the implications of the FDA decision with experts in the care of Alzheimer and investigators involved in the clinical development of the Biogen agent throughout last week. We'll continue those conversations this week.
To catch up on all of our aducanumab coverage, click here.
The American Academy of Sleep Medicine's Annual Meeting, SLEEP 2021, may have wrapped up on Sunday, but NeurologyLive's coverage of the meeting will extend through this week and beyond. It includes key updates from the virtual conference floor, including the latest data on novel therapeutic approaches to migraine care, recaps of study presentations, and in-depth interviews with experts and opinion leaders who attended the meeting.
To catch up on the latest from SLEEP 2021, click here.
The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, also goes live on Wednesday, June 16. This week, it features Michael Thorpy, MD, to discuss Avadel's investigational agent for the treatment of narcolepsy FT218 and the trow of data presented at SLEEP 2021. Thorpy, the director of the Sleep-Wake Disorders Center at Montefiore Medical Center, detailed the mechanism of the drug, its weight-related benefits, and its ability to perform well regardless of stimulant use. He also touched upon the progress that the field has made in treating narcolepsy, and where the greatest unmet needs currently lie.
To check out the prior NeuroVoices conversations, click here.
Throughout the week, the new NeurologyLive Peers & Perspectives series, "Management of Tuberous Sclerosis Complex," will air additional episodes featuring perspectives from Elizabeth Thiele, MD, PhD, and Peter Crino, MD, PhD, who discuss the diagnosis and management of tuberous sclerosis complex (TSC) as well as unmet needs in the field, the role of genetic testing, novel therapies for TSC, and the transition from pediatric to adult care, among other topics.
To catch up on the series, click here.
On Friday, June 18, episode 40 of the NeurologyLive "Mind Moments" podcast will premiere. This time, the show will feature an exclusive conversation with Michael J. Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore Medical Center, and professor of neurology at our Albert Einstein College of Medicine. He sat down to detail the current clinical knowledge of the investigational narcolepsy drug FT218, his takeaways from the annual SLEEP meeting, as well as to share his perspective on the current status of care for sleep disorders and how it's been affected by the pandemic and incorporation of telemedicine.
To subscribe on your favorite podcast player, click here.
This week the MJH Life Sciences Medical World News streaming channel is airing fresh new episodes of your favorite shows on a daily basis. This week, NeurologyLive will be contributing to Behind the Science with Gina Mauro, which will air a conversation with a number of MS experts on Wednesday, June 16, including Daniel Reich, MD, PhD; Ilena George, MD; Kimberley Allen-Philbey, PhD-candidate; Spencer Hutto, MD; Stephanie Blandford, MSc, PhD-candidate; and Yujie Wang, MD. Additionally, on Friday, June 18, an episode of Inside the Practice will feature our conversation with Julie Parsons, MD, about Children's Hospital Colorado and its Complex Drugs Program.
To catch up and check out what's on the Medical World News channel now, click here.
The NeurologyLive Peer Exchange series, "Redefining Treatment Outcomes in Dravet Syndrome," is premiering new episodes! The series, which offers recommendations for the diagnosis, treatment, and management of patients with Dravet syndrome, features Joseph Sullivan, MD; Trevor J. Resnick, MD; Elizabeth A. Thiele MD, PhD; and Elaine C. Wirrell, MD. Thus far, the group has provided an overview of Dravet syndrome and explored why the early diagnosis is vital to care, which patient profiles should be noted for ordering genetic testing, and what to do with those results.
To catch up on the series, click here.